Shreya Madhavaram

Other News

News Update

FDA Accepts Application for Gazyva® (obinutuzumab) to Treat SLE

April 21, 2026
The U.S. Food and Drug Administration has accepted the supplemental Biologics License Application from Genentech for Gazyva® (obinutuzumab) to treat systemic lupus erythematosus (SLE), the most common form of...
News Update

New Phase 2 Data Showed that Litifilimab Significantly Reduced Disease Activity in Cutaneous Lupus Erythematosus 

March 30, 2026
Lupus Therapeutics, clinical affiliate of the Lupus Research Alliance, welcomes new results from the Phase 2 part of the...
News Update

Stay Well with Lupus: Tips for Meditation, Movement, and Stress Management 

March 24, 2026
Living with lupus means managing physical symptoms, emotional ups and downs, and the everyday challenges that come with an autoimmune...